Day: February 25, 2022

MediOrbis Announces Expanded Navigation and Assistance Programs: Specialty Telemedicine Programs to Now Also Include Enhanced Member Information and Guidance

MediOrbis TM Announces Expanded Navigation and Assistance Programs: Specialty Telemedicine Programs to Now Also Include Enhanced Member Information and Guidance...

NLS Pharmaceutics to Participate in the SACHS 15th Annual European Life Sciences Virtual CEO Forum and a Fireside Chat with Maxim Analyst in March

ZURICH, SWITZERLAND / ACCESSWIRE / February 25, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...

POINT Biopharma Announces Abstract Publication of Dosimetry Data Findings from the Lead-In Cohort of the SPLASH trial in mCRPC at the 2022 SNMMI Mid-Winter & ACNM Annual Meeting

Dosimetry data demonstrated PNT2002 has a​ favorable and safe dosimetry profile in the patient population and dose regimen being studied...

error: Content is protected !!